Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/1/11 → 02/9/16 |
Funding
- Sunesis Pharmaceuticals Incorporated: $45,861.00
A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine in Patients with First Relapsed of Refractory Acute Myeloid Leukemia (VALOR)
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Lan, Fengshuo (CoPI)
- Richard, Shambavi (CoPI)
Project: Research